Stener Kvinnsland

Biochemistry, Genetics and Molecular Biology · Life Sciences

33h-index3.9kcitations138works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(44), Cancer Treatment and Pharmacology(20), Cancer Risks and Factors(12), Pharmacogenetics and Drug Metabolism(11), Breast Cancer Treatment Studies(10)

Publications138 total

Alfred Ingvar Halstensen
Tidsskrift for Den norske legeforening·2025Open Access
Jan Erik Varhaug
Tidsskrift for Den norske legeforening·2018Open Access
9 Prospects for Alternating Endocrine Therapy
Contemporary therapy·2015
Priority Setting in Hospital Care
Oxford University Press eBooks·2014
Godt skrevet om ledelse av helsetjenester
Tidsskrift for Den norske legeforening·2013Open Access
Minneord
Tidsskrift for Den norske legeforening·2011Open Access
Welche Hormontherapie bei fortgeschrittenem Mammakarzinom des Mannes?
DMW - Deutsche Medizinische Wochenschrift·2008· 1 cited
Health technology assessment and implications for clinical practice: the case of prostate cancer screening
Scandinavian Journal of Clinical and Laboratory Investigation·2003· 4 cited
European Code Against Cancer and scientific justification: third version (2003)
Annals of Oncology·2003· 307 citedOpen Access
Adjuvant endocrine treatment (goserelin vs tamoxifen) in pre-menopausal patients with operable node positive stage II breast cancer. A prospective randomized national multicenter study
European Journal of Surgical Oncology·2002· 22 cited
[The radiotherapy satellite in Kristiansand--a model for Norwegian regional hospitals?].
PubMed·2001· 1 cited
High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment
European Journal of Cancer·2000· 62 cited
Hormonal therapy in breast cancer and predominant visceral disease: effectiveness of the new oral aromatase inactivator, Aromasin® (exemestane), in advanced breast cancer patients having progressed on antiestrogens
European Journal of Cancer·1999· 10 cited
The leucocyte nadir, a predictor of chemotherapy efficacy?
British Journal of Cancer·1999· 36 citedOpen Access
Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III).
Breast Cancer Research and Treatment·1999· 112 cited
[Cancer research in Scandinavia, a "falling star"?].
PubMed·1998
Activity of exemestane, an irreversible, oral, aromatase inhibitor in metastatic postrnenopausal breast cancer patients (MBC) failing tamoxifen (TAM)
European Journal of Cancer·1998· 7 cited
Prospective findings in breast cancer kindreds: annual incidence rates according to age, stage at diagnosis, mean sojourn time, and incidence rates for contralateral cancer
The Breast·1998· 21 citedOpen Access
Influence of Droloxifene on Metastatic Breast Cancer as First-Line Endocrine Treatment
Acta Oncologica·1998· 15 citedOpen Access
Inherited Mutations in PTEN That Are Associated with Breast Cancer, Cowden Disease, and Juvenile Polyposis
The American Journal of Human Genetics·1997· 280 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Per Magne Ueland(8), Per Eystein Lønning(8), Lars J. Vatten(8), Oscar A. Lea(5), S. Gundersen(5), Ernst A. Lien(4), Steinar Lundgren(4), Hans E. Fjøsne(4), Jon Arne Søreide(4), Ketil Heimdal(3), Pål Møller(3), Terje Engan(3), Ingrid S. Gribbestad(3), Steffen B. Petersen(3), Jostein Krane(3), Jan Erik Varhaug(3), Olbjørn Klepp(3), Eiliv Lund(3), Steinar Tretli(3), PerEystein L�nning(3)